Organogenesis Holdings Inc - Class A — Cash Flow (NASDAQ:ORGO) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 6.8 M61.98 M24.86 M30.92 M14.21 M10.31 M 10.31 M Cash from investing activities 24.83 M31.22 M33.9 M24.36 M10.03 M14.15 M 14.15 M Cash from financing activities 42.47 M1.04 M2.2 M5.5 M27.64 M17.36 M 17.36 M Free cash flow -14.34 M30.76 M-9.04 M6.55 M4.18 M-3.84 M -3.84 M

新闻

Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript

OrganogenesisQ4每股收益及营收超出预期

Organogenesis Holdings将坎顿设施租约延长至2032年

Organogenesis Holdings extends leases for Canton facilities through 2032

Coupang and Regencell among market cap stock movers on Friday

BTIG在CMS LCD决策后维持Organogenesis股票买入评级

Organogenesis stock holds Buy rating at BTIG after CMS LCD decision

Organogenesis股价在提交膝关节炎治疗FDA申请后上涨

Organogenesis stock rises after initiating FDA application for knee arthritis treatment

Organogenesis启动膝关节炎治疗方案FDA滚动审查

Organogenesis begins FDA rolling review for knee arthritis treatment

Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Adagio Medical Holdings (NASDAQ:ADGM), Aldeyra Therapeutics (NASDAQ:ALDX)